HYDROCHLOROTHIAZIDE INTENSOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydrochlorothiazide Intensol, and what generic alternatives are available?
Hydrochlorothiazide Intensol is a drug marketed by Roxane and is included in one NDA.
The generic ingredient in HYDROCHLOROTHIAZIDE INTENSOL is hydrochlorothiazide. There are thirty-two drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hydrochlorothiazide Intensol
A generic version of HYDROCHLOROTHIAZIDE INTENSOL was approved as hydrochlorothiazide by PRINSTON INC on March 29th, 2002.
Summary for HYDROCHLOROTHIAZIDE INTENSOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 134 |
Patent Applications: | 3,812 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HYDROCHLOROTHIAZIDE INTENSOL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for HYDROCHLOROTHIAZIDE INTENSOL
US Patents and Regulatory Information for HYDROCHLOROTHIAZIDE INTENSOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roxane | HYDROCHLOROTHIAZIDE INTENSOL | hydrochlorothiazide | SOLUTION;ORAL | 088588-001 | Jul 2, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |